Mei Ri Jing Ji Xin Wen·2025-11-24 10:18Group 1 - The core point of the article is that Haiprui (SZ 002399) announced the convening of its 18th meeting of the 6th Board of Directors on November 24, 2025, to discuss the cancellation of the supervisory board and amendments to the company's articles of association and related governance systems [1] - For the first half of 2025, Haiprui's revenue composition shows that the pharmaceutical manufacturing industry accounted for 99.97%, while other industries contributed only 0.03% [1] - As of the time of reporting, Haiprui's market capitalization is 17.2 billion yuan [1] Group 2 - The article also mentions that Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a floating profit of 24.92 million yuan for the actual controller and his brother [1]